Showing results (291-300 of 344) with videos related to
Sort By:
Pageof 35
The American Journal of Gastroenterology|April 14, 2025
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter StudyGian Paolo Caviglia, Arianna Ferro, Roberta D'Ambrosio, et al.Gastroenterology|January 22, 2013
Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosisYujin Hoshida, Augusto Villanueva, Angelo Sangiovanni, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 18, 2013
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma, , , et al.Scientific Reports|March 8, 2019
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver DiseaseSerena Pelusi, Guido Baselli, Alessandro Pietrelli, et al.Gastroenterology|March 23, 2011
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis CJordi Bruix, Thierry Poynard, Massimo Colombo, et al.Journal of Viral Hepatitis|December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life settingMassimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.The American Journal of Gastroenterology|August 16, 2022
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varicesVincenza Calvaruso, Ciro Celsa, Roberta D'Ambrosio, et al.Journal of Hepatology|September 9, 2014
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovirGeorge V Papatheodoridis, George N Dalekos, Cihan Yurdaydin, et al.Gastroenterology|February 12, 2009
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapyThierry Poynard, Massimo Colombo, Jordi Bruix, et al.Hepatology (Baltimore, Md.)|October 31, 2015
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infectionMaria Antonella Burza, Benedetta Maria Motta, Rosellina Margherita Mancina, et al.Pageof 35